• Santiago G Pigretti, Cristian Isaac, Clarisa Cea, María M Esnaola, Mariana Riveros, Virginia Tejada Jacob, Miriam Weinberg, Maria L Posadas Martinez, Delfina Cirelli, Mariana A Burgos, Máximo Zimerman, and Marina Romano.
• Hospital Central de Mendoza, Argentina. E-mail: spigretti@gmail.com.
• Medicina (B Aires). 2023 Aug 1; 83 Suppl 3: 1401-40.

AbstractThere is a wealth of information on early pharmacological supportive treatment for early rehabilitation following acute ischemic stroke. This review aims to provide healthcare professionals involved in rehabilitating patients with a summary of the available evidence to assist with decision-making in their daily clinical practice. A search for randomized clinical trials and observational studies published between 1/1/2000 and 28/8/2022 was performed using PubMed, Cochrane and Epistemonikos as search engines with language restriction to english and spanish. The selected studies included patients older than 18 with acute ischemic stroke undergoing early rehabilitation. The outcomes considered for efficacy were: motor function, language, and central pain. The selected pharmacological interventions were: cerebrolysin, levodopa, selegiline, amphetamines, fluoxetine, citalopram, escitalopram, antipsychotics, memantine, pregabalin, amitriptyline and lamotrigine. Evidence synthesis and evaluation were performed using the GRADE methodology. This review provided a summary of the evidence on pharmacological supportive care in early rehabilitation of post-acute ischemic stroke patients. This will make it possible to improve current recommendations with the aim of collaborating with health decision-making for this population.

9 keywords...

hide…